Literature DB >> 21987759

Unconventional secretion of Ebola virus matrix protein VP40.

Olivier Reynard1, St Patrick Reid, Audrey Page, Mathieu Mateo, Nathalie Alazard-Dany, Hervé Raoul, Christopher F Basler, Viktor E Volchkov.   

Abstract

The Ebola virus matrix protein VP40 plays an essential role in virus assembly and budding. In this study we reveal that transient VP40 expression results in the release into the culture medium of substantial amounts of soluble monomeric VP40 in addition to the release of virus-like particles containing an oligomeric form of this protein as previously described. We show that VP40 secretion is endoplasmic reticulum/Golgi-independent and is not associated with cell death. Soluble VP40 was observed during Ebola virus infection of cells and was also found in the serum of virus-infected animals albeit in lower amounts. Unconventional secretion of VP40 may therefore play a role in Ebola virus pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987759      PMCID: PMC3189981          DOI: 10.1093/infdis/jir305

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus.

Authors:  R W Ruigrok; G Schoehn; A Dessen; E Forest; V Volchkov; O Dolnik; H D Klenk; W Weissenhorn
Journal:  J Mol Biol       Date:  2000-06-30       Impact factor: 5.469

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.

Authors:  Mathieu Mateo; Caroline Carbonnelle; Olivier Reynard; Larisa Kolesnikova; Kirill Nemirov; Audrey Page; Valentina A Volchkova; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.

Authors:  O Reynard; V Mokhonov; E Mokhonova; J Leung; A Page; M Mateo; O Pyankova; M C Georges-Courbot; H Raoul; A A Khromykh; V E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Molecular characterization of guinea pig-adapted variants of Ebola virus.

Authors:  V E Volchkov; A A Chepurnov; V A Volchkova; V A Ternovoj; H D Klenk
Journal:  Virology       Date:  2000-11-10       Impact factor: 3.616

6.  Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus.

Authors:  V A Volchkova; H D Klenk; V E Volchkov
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

7.  Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.

Authors:  Kathleen C Prins; Sebastien Delpeut; Daisy W Leung; Olivier Reynard; Valentina A Volchkova; St Patrick Reid; Parameshwaran Ramanan; Washington B Cárdenas; Gaya K Amarasinghe; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

8.  A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2.

Authors:  Koen Temmerman; Antje D Ebert; Hans-Michael Müller; Irmgard Sinning; Ivo Tews; Walter Nickel
Journal:  Traffic       Date:  2008-04-16       Impact factor: 6.215

9.  Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

Authors:  Kelly L Warfield; Dana L Swenson; Gene G Olinger; Warren V Kalina; M Javad Aman; Sina Bavari
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

10.  Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2.

Authors:  Walter Nickel
Journal:  J Cell Sci       Date:  2007-07-15       Impact factor: 5.285

View more
  7 in total

1.  Investigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis.

Authors:  Emmanuel Adu-Gyamfi; Michelle A Digman; Enrico Gratton; Robert V Stahelin
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

2.  Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Authors:  Matt L Boisen; Darin Oottamasathien; Abigail B Jones; Molly M Millett; Diana S Nelson; Zachary A Bornholdt; Marnie L Fusco; Dafna M Abelson; Shun-Ichiro Oda; Jessica N Hartnett; Megan M Rowland; Megan L Heinrich; Marjan Akdag; Augustine Goba; Mambu Momoh; Mohammed Fullah; Francis Baimba; Michael Gbakie; Sadiki Safa; Richard Fonnie; Lansana Kanneh; Robert W Cross; Joan B Geisbert; Thomas W Geisbert; Peter C Kulakosky; Donald S Grant; Jeffery G Shaffer; John S Schieffelin; Russell B Wilson; Erica Ollmann Saphire; Luis M Branco; Robert F Garry; S Humarr Khan; Kelly R Pitts
Journal:  J Infect Dis       Date:  2015-07-30       Impact factor: 5.226

3.  The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress.

Authors:  Smita P Soni; Emmanuel Adu-Gyamfi; Sylvia S Yong; Clara S Jee; Robert V Stahelin
Journal:  Biophys J       Date:  2013-05-07       Impact factor: 4.033

4.  FAM134B, the Selective Autophagy Receptor for Endoplasmic Reticulum Turnover, Inhibits Replication of Ebola Virus Strains Makona and Mayinga.

Authors:  Abhilash I Chiramel; Jonathan D Dougherty; Vinod Nair; Shelly J Robertson; Sonja M Best
Journal:  J Infect Dis       Date:  2016-08-10       Impact factor: 5.226

5.  Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.

Authors:  Michelle L Pleet; James Erickson; Catherine DeMarino; Robert A Barclay; Maria Cowen; Benjamin Lepene; Janie Liang; Jens H Kuhn; Laura Prugar; Spencer W Stonier; John M Dye; Weidong Zhou; Lance A Liotta; M Javad Aman; Fatah Kashanchi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

6.  Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111.

Authors:  Aaron E Lin; William E Diehl; Yingyun Cai; Courtney L Finch; Chidiebere Akusobi; Robert N Kirchdoerfer; Laura Bollinger; Stephen F Schaffner; Elizabeth A Brown; Erica Ollmann Saphire; Kristian G Andersen; Jens H Kuhn; Jeremy Luban; Pardis C Sabeti
Journal:  Viruses       Date:  2020-01-15       Impact factor: 5.048

7.  Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.

Authors:  Haley L DeMers; Shihua He; Sujata G Pandit; Emily E Hannah; Zirui Zhang; Feihu Yan; Heather R Green; Denise F Reyes; Derrick Hau; Megan E McLarty; Louis Altamura; Cheryl Taylor-Howell; Marcellene A Gates-Hollingsworth; Xiangguo Qiu; David P AuCoin
Journal:  PLoS Negl Trop Dis       Date:  2020-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.